# WikiJournal Preprints/How do we can control SARS-CoV-2/ Covid -19 pandemic through various clinical and public health approaches?

WikiJournal Preprints Open access • Publication charge free • Public peer review
WikiJournal of Science
WikiJournal of Humanities
WikiJournal of PPB
Editorial guidelines Ethics statement Bylaws Indexing Financials and reports 1-year/3-year plan Proposed platform Meeting minutes Calendar
WikiJournal User Group is a publishing group of open-access, free-to-publish, Wikipedia-integrated academic journals. <seo title=" Wikiversity Journal User Group, WikiJournal Free to publish, Open access, Open-access, Non-profit, online journal, Public peer review "/>
This article has been declined for publication by the WikiJournal of Medicine.
It is archived below as a record. Discussion can be viewed here.
First submitted: 31 Dec 2021 Declined: 26 Jan 2022 Reviewer comments
QID: Q110552322
Suggested (provisional) preprint citation format: Piyush Kumar. "How do we can control SARS-CoV-2 / Covid-19 pandemic through various clinical and public health approaches?". WikiJournal Preprints. Wikidata Q110552322.
License:
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction, provided the original author and source are credited.

## Article information

Author: Piyush Kumar
* ↑ Health Department, Bihar Health Services, Government of Bihar, India
* ↑ Health Department, Bihar Health Services, Government of Bihar, India

## Abstract

Objective The main objective of this study is to illustrate the key features of Covid -19 virus & other factors responsible for continuation and recurrence of this pandemic. The next objective is to illustrate various strategies and approaches to prevent epidemic through assessment of important parameters and indicators (see figure 1) to control the ongoing disaster and hazards of pandemic.
Setting and design Different aspects of Covid -19 structural variations and its effect is analysed. Text and figure details about epidemiological triad and various steps to be monitored and modified are outlined. The clinical and public health approaches is explained in stepwise manner in figure1.
Methodology The methods to control the pandemic under clinical and public health approach is discussed here. The methods to control perpetuation of Covid -19 can be achieved by the controlling and modifying way of infections spread and other determinant. Both clinical and public health approach methods are outlined with their importance in this article in brief.
Result Several factors are responsible for the continuation of the pandemic. The CCP (Covid -19control plan) with public health and clinical approaches can be utilized to prevent further spread in different settings.
Conclusion In the epidemiological triad we have agent/host/environment; the public health approach will deal with these three parameters. The clinical approach targets sick individuals (host) infected with SARS-Cov-2/Covid-19.The control of pandemic can be achieved only through a definite universal control plan incorporating both clinical and public health approach. See figure 1.

## Background

The SARS-CoV-2/ Covid -19 pandemic is still going on and globally healthcare system is overstressed with this new burden added with previous NCD & CD in existence. The First human case of this global pandemic was reported from Wuhan city of China in December 2019. The SARS-CoV-2/ Covid -19 coronavirus belongs to a large family of coronavirus. Usually they cause respiratory infection in humans like other respiratory viruses such as rhinoviruses/ human respiratory syncytial virus/ parainfluenza viruses/ adenoviruses/influenza A & B viruses / enteroviruses / herpes simplex viruses/ human metapneumoviruses etc.
Globally new covid-19 cases are rising again or we can say alternatively that incidence rate is increasing. In the last week of March 2021 the new cases reported globally are more than 3.8 million. At the same time the number of deaths also increased consecutively for the second consecutive week. The deaths increased by 5 % compared to previous week. The total number of death for above mentioned period was over 64000 new deaths. The more alarming fact is that all regions have reported an increase in incidence rate in last week of March 2021. If we talk about deaths then except African region all regions reported an increase in the number of deaths due to covid-19. Added to above facts still the European region with region of Americas are on the top accounting for 80 % of all cumulative cases and deaths. There is sharp rise in south East Asia region or actually it’s the largest increase on global basis that is 21 % increase in deaths with continued increasing trends in the 3rd consecutive week. The south East Asian region is also having a huge population as well as many nations are in developing stage with stressed and overburdened health system.
There are two main approaches to this pandemic control. The clinical approach based on individuals and public health approach based on population. There is requirement of a universal control plan through which pandemic can be controlled, eliminated & eradicated.

### Objective

The main objective of this study is to illustrate the key features of Covid -19 virus responsible for continuation and recurrence of this pandemic as well as current latest status in brief. The latest scenario of covid-19 pandemic is as follow: see table 1 --
Table 1 - Newly reported and cumulative COVID-19 confirmed cases and deaths, by WHO Region, as of 28 March 2021- source – WHO
| WHO Region | New cases in last 7 days (%) | Change in new cases in last 7 days * | Cumulative cases (%) | New deaths in last 7 days (%) | Change in new deaths in last 7 days * | Cumulative deaths (%) |
| Americas | 1 306 017 (34%) | 11% | 55 243 776 (44%) | 32 176 (50%) | 4% | 1 331 419 (48%) |
| Europe | 1 641 672 (43%) | 11% | 44 191 579 (35%) | 23 778 (37%) | 7% | 954 829 (34%) |
| South-East Asia | 437 060 (11%) | 46% | 14 619 886 (12%) | 2 947 (5%) | 21% | 217 737 (8%) |
| Eastern Mediterranean | 270 884 (7%) | 3% | 7 395 085 (6%) | 3 428 (5%) | 5% | 156 891 (6%) |
| Africa | 62 286 (2%) | 22% | 3 061 438 (2%) | 1 340 (2%) | -6% | 77 446 (3%) |
| Western Pacific | 84 395 (2%) | 32% | 1 859 933 (1%) | 518 (1%) | 7% | 31 361 (1%) |
| Global | 3 802 314 (100%) | 14% | 126 372 442 (100%) | 64 187 (100%) | 5% | 2 769 696 (100%) |
The whole group of coronavirus is very peculiar. They are pleomorphic, single stranded RNA viruses measuring 100-160 nm in diameter. There are several factors responsible for the continuation of covid-19 pandemic. Broadly we can look at the epidemiological triad i.e. agent, host and environmental factors. The next objective is to illustrate various strategies and approaches to prevent epidemic through clinical and public health approach.

## Setting and Design

Different aspects of Covid -19 structural variations (see table 2) and its effect will be analysed. Details about epidemiological triad are outlined.
Covid -19 agent is having continuous variations one of the factors responsible for the ongoing covid-19 pandemic. These viruses have crown like appearance produced by club shaped projections that studs the viral envelope. The coronavirus group actually infects a wide variety of animals of different species. These are divided into three antigenic and genetic groups.

## Methodology

The explanation will be given to title through analysis of several accredited findings. The cause of perpetuation of Covid -19 can be understood by the way of infections and other related factors. SARS (SARS – CoV) CORONAVIRUSES causing human infections falls in group 1 and 2. The human isolates were HCoV-229E and HCoV-OC43. SARS-CoV was earlier considered to be a novel group of viruses (novel coronavirus, n covid-19) but now they are placed in group 2 (SARS-CoV-2). The fully sequenced have shown minimal variations.
The main problem in understanding morphology and other important determinants to know more about this virus is that it’s difficult to cultivate it in vitro added with continuous variations. We can grow some strains in human tracheal organ cultures but quite difficult to grow in tissue culture. SARS-CoV is exceptional as it can be grown in African green monkey kidney (Vero –E6) cells facilitating to know more about this virus.
Generally human coronavirus infections present globally. Seroprevalence studies have demonstrated this fact. The seasonal trends shows that infection is more common in late fall, winter, and early spring times. If we look at the history SARS-2002/2003 – south china outbreak begin with 8096 recognised cases in 28 countries & added to this 90 % of cases occurred in china and Hongkong. Now the world is moving very fast or we can say the host factors related spread have exaggerated the pandemic added with various climatic changes. That time the natural reservoir of SARS-CoV appeared to be horseshoe bat. The 2002-2003 outbreaks thought to be originated due to human contacts with infected domestic animals. The striking fact is that in 2002-2003 as well as 2019-2020-2021 most cases spread from human to human and there are multiple ways of spread particularly respiratory droplets. The 2002 outbreak ceased in 2003 but 2019 outbreak is going on and global fast movement is one of the most important factors. The super spreaders may remain symptomless while spreading the virus.
The Public health approach is focussed on epidemiological triad of agent, host and environment.
Agent factors- The agent factors of key importance are different strains variations see table 2 & their structure.
Table 2: Overview of variants of interest (VOIs), as of 30 March 2021 – source – WHO
| Next strain clade | 20C | 20C/S.452R | 20B/S.484K | Not yet assigned | 20C | 20C |
| PANGO lineage | B.1.525 | B.1.427/B.1.429 | B.1.1.28.2, alias P.2 | B.1.1.28.3 alias P.3 | B.1.526 (with E484K or S477N) | B.1 descendant with 9 mutations |
| GISAID clade | G/484K.V3 | GH/452R.V1 | GR | Not yet assigned | GH | GH |
| Alternate names | | CAL.20C/L452R | | PHL-B.1.1.28 | | |
| First detected by | United Kingdom and Nigeria | United States of America | Brazil | Philippines and Japan | United States of America | France |
| First appearance | December 2020 | June 2020 | April 2020 | February 2021 | November 2020 | January 2021 |
| Key spike mutations | H69-V70 deletion; Y144 deletion; Q52R; E484K; Q677H; D614G; and F888L | L452R; W152C; S13I; and D614G | L18F; T20N; P26S; F157L; E484K; D614G; S929I; and V1176F | 141-143 deletion; E484K; N501Y; and P681H | L5F; T95I; D253G; D614G; A701V; and E484K or S477N | G142 deletion; D66H; Y144V; D215G; V483A; D614G; H655Y; G669S; Q949R; and N1187D |
Different strains vary in virulence, infectivity, pathogenicity, reproduction resulting in different case fatality, mortality & morbidity rates. The prevalence rate and incidence rate is also dependent on above factors. The TCID 50 and cycle threshold values are equally important to assess the severity of infection. The attack rate, secondary attack rate and reproduction number should be taken into account while doing assessment of agent factors. Without having sound knowledge of above mentioned agent factors it’s just impossible to effectively control this pandemic-see figure 1.
Host factors- As we are aware of the fact that corona viruses infects a variety of hosts we must have a proper plan to avoid contacts with other animals etc known to be reservoir of covid-19. The human beings are infected from covid-19 through droplets and many other modes. Here the infection can be dealt through clinical approach, public health or preventive approach. Best is a combination of both approaches. See figure 1. The public health approach as well as clinical approach should work in co-ordination to achieve the desired results. The governance should have a clear data regarding health workforce, finance, available no. of beds and several other parameters illustrated in figure 1 to act in effective way to provide healthcare to persons who need it most.
There may be different modes of transmission for SARS-CoV-2, including contact, droplet, airborne, fomite, faecal-oral, blood borne, mother-to-child, and animal-to-human transmission. Infection with SARS-CoV-2 primarily causes respiratory illness ranging from mild disease to severe disease and death, and some people infected with the virus never develop symptoms.
Environmental factors- The environmental factors of key importance are modifications and sanitary measures required to halt the progress of pandemic.
How to make our environment safer?
* Avoid these 3Cs: spaces that are closed crowded or involve close contact.
** Outbreaks have been reported in public places with gatherings such as restaurants, choir practices, fitness classes, nightclubs, offices and places of worship where people have gathered, often in crowded indoor settings where they talk loudly, shout, breathe heavily or sing.
** The risks of getting COVID-19 are higher in crowded and inadequately ventilated spaces where infected people spend long periods of time together in close proximity. These environments are where the virus appears to spread by respiratory droplets or aerosols more efficiently, so taking precautions is even more important.
* Meet people outside. Outdoor gatherings are safer than indoor ones, particularly if indoor spaces are small and without outdoor air coming in.
* Avoid crowded or indoor settings but if you can’t, then take precautions:
o Open a window. Increase the amount of ‘natural ventilation’ when indoors.
o Wear a mask.

## Result

Several factors are responsible for the continuation of the pandemic. The pathogenesis of the strains causing common cold e.g. HCoV-229E and HCoV-OC43 says that they infect ciliated epithelial cells in the nasopharynx via the aminopeptidase 1 receptor (group 1) or a sialic acid receptor. Viral replication leads to a cascade of events manifested externally as common cold symptoms similar to other virus group called rhinoviruses.
SARS-CoV infects the respiratory tract via ACE 2 receptors. The systemic illness is manifested more or less depending upon immune status as well as associated morbidity conditions. The systemic manifestations include variety of signs and symptoms and sometime it’s symptomless. The study of pulmonary pathology will reveal more findings in coming days. One key finding is that earlier 2002-2003 outbreaks have many similarities with ncovid-19. The disease is milder in children and ARDS is also found in ncovid-19 severe cases. Besides this symptoms of common cold etc are very much similar. The incubation period is 1-14 days range. In earlier cases 2002-2003 laboratory findings have shown in SARS lymphopenia present in approx. 50 % cases resulting in decreased immunity. Mostly T cells CD4+ (helper t cells) were affected and also CD8+T cell as well as natural killer to some extent.
The detailed information about ncovid-19 is yet to be finalised as several strains have been found and the trends shows that these variations will keep going. The global market has several accredited vaccines duly recognised by World Health Organisation. The final analysis and results can be declared only after a large population of world get vaccinated and with the development of herd immunity the predictions can be clearer.

## Conclusion

In the epidemiological triad we have agent/host/environment. For controlling this pandemic of covid-19 as per public health approach our mind should be clear that we have to have a keen and deep view of epidemiological triad. The epidemiological triad (concept of causation) consist of agent (causative factor), host (those who get infected from agent) and the surroundings (ecology, environment etc.).
The modification at one of the above factors will modify other factors positively or negatively. Now we have to keep in mind that
Ø The new strains will keep on evolving as it’s a natural event and practically impossible to change this factor of mutation etc.
Ø We can do a lot at the host factors and lots of guidelines are issued by national/international organisations particularly WHO. The importance of vaccination should be considered globally as well as equity in vaccination etc. At the same time the efficacy of vaccines on all different strains is yet unknown.
Ø At the environmental level also we can keep our environment safe by adapting WASH and other guidelines to make world a safer place for everyone.
Ø At last but not least global coordination is required to stop this pandemic and any future mutations increasing virulence of covid-19 will have a detrimental effect globally if not stopped now through international collaborations.

## Declarations

-This paper has not been previously published and is not currently under consideration by another journal. The document is Microsoft word with English (India) language & 2738 words Total.
- Ethics approval and consent to participate: Not applicable. This study has not involved any human or animals in real or for experiments.
-Consent for publication: Not applicable
-Availability of data and materials: The data & materials for study are available as reference link.
-Conflicts of Interest/ Competing Interest
There are no conflicts / competing of interest
- Funding-Self sponsored. No aid taken from individual or agency etc.
- Authors' contributions: The whole work is solely done by the Author - Dr Piyush Kumar, M.B.B.S. - Sri Krishna Medical College, EMOC- General Medical Officer- Bihar Health Services- Government of Bihar, India.
- Acknowledgements- I am thankful to advocate Anupama my wife and daughters Aathmika and Atheeva for cooperation.
- Author information: The author is currently working as general medical officer for the government of Bihar.
-Financial Support & sponsorship: Nil
The article preprint is also submitted as preprint to various preprint server and preprint is having doi as well as searchable on various search engine. The article is not published in any peer reviewed journal.

## Additional information
### Acknowledgements

I am thankful to advocate Anupama my wife and daughters Aathmika and Atheeva for cooperation.

### Competing interests

There are no conflicts / competing of interest.

### Ethics statement

Not applicable. This study has not involved any human or animals in real or for experiments.